Market Research Report
Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025
|Published by||QYResearch||Product code||606167|
|Published||Content info||136 Pages
Delivery time: 2-3 business days
|Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025|
|Published: February 19, 2018||Content info: 136 Pages||
This report studies the Oncolytic Virus Therapy market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Oncolytic Virus Therapy market by product type and applications/end industries.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. The total investment for Oncolytic Virus Therapy developing is around 84 M USD in 2017.
The major players in global Oncolytic Virus Therapy market include:
Geographically, this report is segmented into several key regions, with market size and R&D investment, market share and growth rate of Oncolytic Virus Therapy in these regions, from 2013 to 2025 (forecast), covering:
On the basis on the end users/applications, this report covers: